norcantharidin has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, Y; Huang, X; Jiang, Y; Lee, EY; Li, Y; Lin, HP; Reichel, D; Wang, Z; Xiao, Y; Yang, C | 1 |
| He, Q; Li, Y; Luo, X; Ren, G; Shao, Q; Tan, Y; Xiang, T; Xing, L; Xue, S; Zhang, L | 1 |
2 other study(ies) available for norcantharidin and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Delivery Systems; Humans; Integrin alpha5; Mice, Nude; Nanoconjugates; Neoplasm Invasiveness; Neoplastic Stem Cells; Oligopeptides; Triple Negative Breast Neoplasms; Wnt Signaling Pathway | 2019 |
Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Enzyme Inhibitors; Female; Humans; MAP Kinase Kinase Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Triple Negative Breast Neoplasms | 2019 |